This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignees: Biontech Se, Genmab A+s. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 77 
1 out of 107 
Years Active: 2025-2026
Title: Andreea Ioan: Innovator in Cancer Treatment
Introduction
Andreea Ioan is a prominent inventor based in Utrecht, Netherlands. She has made significant contributions to the field of cancer treatment through her innovative research and development of binding agents.
Latest Patents
Her most notable patent is focused on binding agents that bind to EpCAM and CD137. This invention is particularly useful in treating or preventing tumors or cancer, as well as preventing the progression of these diseases. The patent highlights her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Andreea has worked with leading companies in the biotechnology sector, including Genmab and BioNTech SE. Her experience in these organizations has allowed her to collaborate with some of the brightest minds in the industry, further enhancing her expertise and impact.
Collaborations
Throughout her career, Andreea has collaborated with notable colleagues such as Esther Cornelia Wilhelmina Breij and Lars Guelen. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Andreea Ioan is a trailblazer in the field of cancer treatment, with a focus on innovative binding agents. Her work continues to inspire and pave the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile